Press Release Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer Kymera Therapeutics, Inc. · Jul 27
Press Release Cerence to Announce Fiscal Third Quarter Results on August 6, 2026 Cerence Operating Company · Jul 27
Press Release Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement Scribe Therapeutics Inc. · Jul 27
Press Release Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026 Denali Therapeutics Inc. · Jul 27
Press Release Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) Definitive Healthcare Corp. · Jul 27
Press Release Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 Nyxoah · Jul 27
Press Release Robin Energy Announces Closing of $3.0 Million Public Offering of Common Stock Robin Energy Ltd. · Jul 27
Press Release Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers Organogenesis Holdings Inc. · Jul 27
Press Release Dr. Valinda Nwadike Scholarship for Medical Students Launches to Advance Health Equity and Telehealth Access in the Pre-Med Pipeline Dr. Valinda Nwadike Scholarship · Jul 27
Press Release Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026 Quantum-Si Incorporated · Jul 27
Press Release WEBTOON Entertainment Inc. to Report Second Quarter 2026 Financial Results on August 10, 2026 WEBTOON Entertainment Inc. · Jul 27